Clinical Trial Update: Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating ampicillin plus ceftriaxone for Enterococcus faecalis infective endocarditis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infective Endocarditis

Drugs mentioned

• AMPICILLIN (AMPICILLIN)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Endocarditis, Infective | Phase 4 | Status: RECRUITING